Suzhou Siran Biotechnology Co., Ltd.
蘇州時安生物技術有限公司
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-09-09 | Moonwalk Biosciences, Inc. | STORK-F delivery technology; MW101 and related siRNA programs | Not disclosed | Not disclosed | Not disclosed | Preclinical; MW101 in IND-enabling studies |